Funder: National Institutes of Health
Due Dates: May 10, 2025 (Open) | June 10, 2025 (Application) | June 11, 2025 (Expiration)
Funding Amounts: Up to $500,000 direct costs/year; max 5 years; total program funding ~$2.56M/year for 4–6 awards
Summary: Supports research on the molecular and immunological mechanisms by which two or more vaccine adjuvants work together, to inform rational vaccine design.
Key Information: Clinical trials are not allowed; strong focus on mechanistic studies using validated adjuvants in animal and/or human in vitro models.